Medicare’s weight-loss drug discount excludes many who need it most, new cases reveal

Despite a new Medicare pilot programme aimed at making GLP-1 weight-loss medications more affordable, restrictions based on health conditions leave out many patients, including a retired professor with severe obesity and health issues. Jeff La Marca thought he had found…













